Cover Image
Market Research Report

Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Published by IMARC Services Pvt. Ltd. Product code 354155
Published Content info 82 Pages
Delivery time: 1-2 business days
Price
Back to Top
Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
Published: April 29, 2017 Content info: 82 Pages
Description

Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

IMARC's latest study "Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.

Key Questions Answered in This Report:

  • How has the generic drug market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic drug industry?
  • What are the various stages in the value chain of the generic drug industry?
  • What are the key driving factors and challenges in the generic drug industry?
  • How has the generic oncology drug market performed so far and how will it perform in the coming years?
  • What is the structure of the generic drug industry and who are the key players?
  • What is the degree of competition in the generic drug industry?
  • What are the profit margins in the generic drug industry?
  • What are the key requirements for setting up generic drug manufacturing plant?
  • How are generic drug manufactured?
  • What are the various unit operations involved in generic drug plant?
  • What is the total size of land required for setting up generic drug plant?
  • What are the machinery requirements for setting up generic drug plant?
  • What are the raw material requirements for setting up generic drug plant?
  • What are the packaging requirements for generic drug?
  • What are the transportation requirements for generic drug?
  • What are the utility requirements for setting up generic drug plant?
  • What are the manpower requirements for setting up generic drug plant?
  • What are the infrastructure costs for setting up generic drug plant?
  • What are the capital costs for setting up generic drug plant?
  • What are the operating costs for setting up generic drug plant?
  • What will be the income and expenditures for generic drug plant?
  • What is the time required to break-even?
Table of Contents
Product Code: SR1018C48_Report

Table of Contents

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Generic Drug Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Region
  • 5.4 Market Forecast
  • 5.5 SWOT Analysis
    • 5.5.1 Strengths
    • 5.5.2 Weaknesses
    • 5.5.3 Opportunities
    • 5.5.4 Threats
  • 5.6 Value Chain Analysis
  • 5.7 Porter's Five Forces Analysis
    • 5.7.1 Overview
    • 5.7.2 Bargaining Power of Buyers
    • 5.7.3 Bargaining Power of Suppliers
    • 5.7.4 Degree of Competition
    • 5.7.5 Threat of New Entrants
    • 5.8.6 Threat of Substitutes
    • 5.8.7 Regulations in the Generics Industry
  • 5.9 Key Market Drivers and Success Factors

6 Global Generic Oncology Drug Market

  • 6.1 Market Overview
  • 6.2 Market Trends
  • 6.3 Top Generic Oncology Drugs
  • 6.4 Market Forecast

7 Global Generic Drug Market: Performance of Key Regions

  • 7.1 USA
  • 7.2 China
  • 7.3 Brazil
  • 7.4 Germany
  • 7.5 France

8 Global Generic Drug Market: Competitive Landscape

  • 8.1 Competitive Structure
  • 8.2 Market Breakup by Key Players
  • 8.3 Key Player Profiles
    • 8.3.1 Teva Pharmaceuticals
    • 8.3.2 Novartis - Sandoz
    • 8.3.3 Mylan
    • 8.3.4 Freseunis
    • 8.3.5 Hospira

9 Generic Oncology Drug Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Detailed Process Flow (Tablets)
  • 9.3 Detailed Process Flow (Injectable)
  • 9.4 Various Types of Unit Operations Involved
  • 9.5 Mass Balance and Raw Material Requirements

10 Project Details, Requirements and Costs Involved

  • 10.1 Land Requirements and Expenditures
  • 10.2 Construction Requirements and Expenditures
  • 10.3 Plant Machinery
  • 10.4 Machinery Pictures
  • 10.5 Raw Material Requirements and Expenditures
  • 10.6 Packaging Requirements and Expenditures
  • 10.7 Transportation Requirements and Expenditures
  • 10.8 Utility Requirements and Expenditures
  • 10.9 Manpower Requirements and Expenditures
  • 10.10 Other Capital Investments

11 Loans and Financial Assistance

12 Project Economics

  • 12.1 Capital Cost of the Project
  • 12.2 Techno-Economic Parameters
  • 12.3 Product Pricing and Margins Across Various Levels of the Supply Chain
  • 12.4 Taxation and Depreciation
  • 12.5 Income Projections
  • 12.6 Expenditure Projections
  • 12.7 Financial Analysis
  • 12.8 Profit Analysis

List of Figures

  • Figure 1: Global: Generic Oncology Drug Industry Overview
  • Figure 2: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2010 - 2016
  • Figure 3: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 - 2022
  • Figure 4: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2016
  • Figure 5: Global: Generic Oncology Drug Industry: SWOT Analysis
  • Figure 6: Global: Generic Oncology Drug Industry: Value Chain Analysis
  • Figure 7: Global: Generic Oncology Drug Industry: Porter's Five Forces Analysis
  • Figure 8: Global: Generic Oncology Drug Industry Overview
  • Figure 9: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2010 - 2016
  • Figure 10: Global: Generic Oncology Drug Market: Top Generic Oncology Drug
  • Figure 11: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 - 2022
  • Figure 12: USA: Generic Drug Market (in Million US$), 2009, 2016 & 2022
  • Figure 13: China: Generic Drug Market (in Million US$), 2009, 2016 & 2022
  • Figure 14: Brazil: Generic Drug Market (in Million US$), 2009, 2016 & 2022
  • Figure 15: Germany: Generic Drug Market (in Million US$), 2009, 2016 & 2022
  • Figure 16: France: Generic Drug Market (in Million US$), 2009, 2016 & 2022
  • Figure 17: Generic Oncology Drug Industry: Profit Margins at Various Levels of the Supply Chain
  • Figure 18: Generic Oncology Drug Manufacturing: Production Cost Breakup (in %)
  • Figure 19: Generic Oncology Drug Manufacturing Plant: Detailed Process Flow
  • Figure 20: Generic Oncology Drug Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 21: Generic Oncology Drug Manufacturing Plant: Proposed Plant Layout
  • Figure 22: Generic Oncology Drug Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

  • Table 1: Global: Generic Drug Market: Key Industry Highlights, 2016 and 2022
  • Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2017-2022
  • Table 3: Global: Generic Oncology Drug Market: Key Industry Highlights, 2016 and 2022
  • Table 4: Generic Oncology Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 5: Generic Oncology Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 6: Generic Oncology Drug Manufacturing Plant: Costs Related to Machinery Unit (in US$)
  • Table 7: Generic Oncology Drug Manufacturing Plant: Raw Material Requirements
  • Table 8: Generic Oncology Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 9: Generic Oncology Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
  • Table 10: Details of Financial Assistance Offered by Financial Institutions
  • Table 11: Generic Oncology Drug Manufacturing Plant: Capital Costs (in US$)
  • Table 12: Generic Oncology Drug Manufacturing Plant: Techno-Economic Parameters
  • Table 13: Generic Oncology Drug Manufacturing Plant: Taxation and Depreciation
  • Table 14: Generic Oncology Drug Manufacturing Plant: Income Projections (in US$)
  • Table 15: Generic Oncology Drug Manufacturing Plant: Expenditure Projections (in US$)
  • Table 16: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
  • Table 17: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
  • Table 18: Generic Oncology Drug Manufacturing Plant: Profit and Loss Account
Back to Top